Study schedule
| Prerandomisation | Day 0 | Postintervention | |||
| 1 month | 6 months | 12 months | |||
| Enrolment | |||||
| Eligibility screen | X | ||||
| Informed consent | X | ||||
| Randomisation | X | ||||
| Interventions | |||||
| Embolisation | X | ||||
| Placebo | X | ||||
| Assessments | |||||
| Demographic variables | X | ||||
| KOOS | X | X | X | X | |
| EQ-5D-5L | X | X | X | X | |
| Global change | X | X | X | X | |
| Six-minute walk test | X | X | X | X | |
| Thirty-second chair stand test | X | X | X | X | |
| Analgesia | X | X | X | X | |
EQ-5D-5L: EuroQol.
Global change: overall change, change in pain, change in physical function.
KOOS, Knee Injury and Osteoarthritis Outcome Score (five scales: pain, symptoms, function in daily living, function in sports and recreational activities, quality of life).